Amedisys (NASDAQ:AMED) just reported results for the second quarter of 2024.
- Amedisys reported earnings per share of $1.32. This was above the analyst estimate for EPS of $1.18.
- The company reported revenue of $591.19 million.
- This was 2.14% better than the analyst estimate for revenue of $578.82 million.